Regulator Demands Reversal of S/77.6M Holcim Expenses; Company Strongly Defends Accounting & Governance
summarizeSummary
Cementos Pacasmayo has filed a comprehensive response to the Peruvian securities regulator (SMV), vehemently defending its accounting treatment of S/77.6 million in "Holcim Expenses" and challenging the SMV's authority to order a reversal of these costs. The SMV alleges violations of IFRS and corporate governance principles.
check_boxKey Events
-
Regulatory Demand for Expense Reversal
The Peruvian securities regulator (SMV) has formally demanded that Cementos Pacasmayo reverse S/77.6 million in "Holcim Expenses" from its 2025 financial statements, alleging IFRS violations and inadequate disclosure.
-
Company's Strong Defense
Cementos Pacasmayo vehemently defends its accounting, stating the expenses are legitimate, either as pre-existing contractual obligations for senior management or standard M&A advisory fees benefiting the company.
-
Challenge to SMV Authority
The company explicitly challenges the SMV's legal authority to "order" accounting reversals and dictate financial reporting, arguing it exceeds supervisory powers and violates due process.
-
Corporate Governance & Disclosure
Cementos Pacasmayo asserts that the expenses were approved by its Board with appropriate abstentions for conflicts of interest and that disclosure was adequate, while the SMV claims insufficient transparency.
auto_awesomeAnalysis
This filing reveals a significant dispute between Cementos Pacasmayo and the Peruvian securities regulator (SMV) over the accounting and disclosure of S/77.6 million (approximately $21 million USD) in expenses related to a potential change of control transaction involving the company's controlling shareholder. The SMV is demanding that Cementos Pacasmayo reverse these expenses, which it claims represent 70% of the company's 2025 net profit, and rectify its financial statements, citing multiple IFRS violations and inadequate transparency.
Cementos Pacasmayo is strongly pushing back, arguing that the expenses (primarily senior management compensation and advisor fees) are legitimate, pre-existing contractual obligations or standard M&A costs that benefit the company and its shareholders. The company also asserts that its Board approved these expenses with proper conflict-of-interest management and that its external auditors issued an unqualified opinion. Crucially, Cementos Pacasmayo challenges the SMV's legal authority to dictate accounting entries and order financial restatements, viewing it as an overreach that violates due process.
The ongoing regulatory scrutiny and the demand for a financial restatement introduce considerable uncertainty and risk for investors. While the company's defense is detailed and robust, the dispute itself highlights potential governance and reporting issues that could impact investor confidence and potentially lead to penalties or further legal action. Investors should monitor the SMV's next steps and any potential impact on the company's financial reporting and stock performance.
At the time of this filing, CPAC was trading at $10.14 on NYSE in the Manufacturing sector, with a market capitalization of approximately $924.4M. The 52-week trading range was $5.10 to $11.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.